How many email patterns does Vicinitas Therapeutics use?

Vicinitas Therapeutics uses 4 known email patterns.

What domain does Vicinitas Therapeutics use for work emails?

Vicinitas Therapeutics uses vicinitastx.com for work email addresses.

Most Common Email Formats at Vicinitas Therapeutics

Vicinitas Therapeutics's most common email format is First.Last@vicinitastx.com (ex. John.Doe@vicinitastx.com), used for 83% of vicinitastx.com addresses. Vicinitas Therapeutics uses 4 email patterns.

@vicinitastx.com

4 patterns

Format	Example	Share of vicinitastx.com
First.Last@vicinitastx.comMost common	John.Doe@vicinitastx.com	83%
FirstLa@vicinitastx.com	JohnDo@vicinitastx.com	8%
F_Last@vicinitastx.com	J_Doe@vicinitastx.com	5%
LFirst@vicinitastx.com	DJohn@vicinitastx.com	4%

Need a specific person's email?

Browse Vicinitas Therapeutics's employee directory (about 3 employees) and reveal verified emails free.

Frequently Asked Questions

What does Vicinitas Therapeutics do?

Vicinitas Therapeutics operates in the Biotechnology Research industry, alongside similar companies like Amneal Pharmaceuticals, Teva Pharmaceuticals and Sanofi. You can visit vicinitastx.com. Explore Vicinitas Therapeutics's company overview page for more information.

What is Vicinitas Therapeutics's email address format?

Vicinitas Therapeutics's email format typically follows the pattern of First.Last@vicinitastx.com; this email format is used 83% of the time. Other contacts within LeadIQ's database had email formats such as FirstLa@vicinitastx.com and F_Last@vicinitastx.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Vicinitas Therapeutics have currently?

Vicinitas Therapeutics has approximately 3 employees as of November 2026. Key team members to contact include Founder: D. N., Vice President, Finance: J. A. and Associate Director: R. Z. For more team information and contact data, explore Vicinitas Therapeutics's employee directory with LeadIQ.

Vicinitas Therapeutics Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

Vicinitas Therapeutics is a biotechnology company focused on targeted protein stabilization using Deubiquitinase Targeting Chimeras (DUBTACs). It aims to address proteins that are abnormally degraded in diseases such as cancer and monogenic disorders, including proteins previously considered undruggable. The company originated from a collaboration between Novartis Institutes for BioMedical Research and the University of California, Berkeley, and is based in South San Francisco, California, with a website at vicinitastx.com. It operates with a small team of 2-10 employees. Reported revenue is between $0 and $1 million.

Most common format

First.Last@vicinitastx.com

Example: John.Doe@vicinitastx.com

4 patterns. See all formats

Verify a Vicinitas Therapeutics email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at Vicinitas Therapeutics

@vicinitastx.com

Need a specific person's email?

Frequently Asked Questions

What does Vicinitas Therapeutics do?

What is Vicinitas Therapeutics's email address format?

How many employees does Vicinitas Therapeutics have currently?

Vicinitas Therapeutics Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.